Page 89 - Read Online
P. 89

Page 10 of 15           Slattery et al. Neuroimmunol Neuroinflammation 2018;5:11  I  http://dx.doi.org/10.20517/2347-8659.2018.05


                                        150


                                      Nitrite (% control)  100



                                        50



                                         0
                                               0                  2                20               50
                                                            P-aminophenol (µmol/L)

                                               0 µmol/L indomethacin             20 µmol/L indomethacin
                                               2 µmol/L indomethacin             50 µmol/L indomethacin

               Figure 8. Effects of p-aminophenol alone or in combination with the non-selective cyclooxygenase inhibitor indomethacin on
               lipopolysaccharide (LPS)-induced nitric oxide release. BV-2 cells were treated for 15 min with various concentrations of indomethacin
               (2, 20, 50 mmol/L), then incubated with different concentrations (2, 20, 50 mmol/L) of p-aminophenol for a further 15 min period,
               before being stimulated with LPS. After 24 h, nitrite concentrations in the BV-2 cell-free supernatants were measured using the Griess
               assay. Data from four independent experiments are normalized against nitrite concentration in samples stimulated in the absence of
               inhibitors. Nitrite concentration in these samples was 27.1 ± 2.6 mmol/L. The effect of treatments was assessed by the two-way analyses
               of variance (ANOVA), followed by Tukey’s post hoc test. **P < 0.01, significantly different from stimulated cells incubated in the absence
               of indomethacin (ANOVA F = 8.05, P = 0.0002);  P < 0.01, significantly different from stimulated cells incubated in the absence of
                                                  ##
               p-aminophenol (ANOVA F = 95.51, P < 0.0001). ANOVA interaction F = 1.34, P = 0.24


                                        150


                                       Nitrite (% control)  100




                                        50


                                         0
                                               0                   2                20               50
                                                                 AM404 (µmol/L)

                                               0 µmol/L indomethacin              20 µmol/L indomethacin
                                               2 µmol/L indomethacin              50 µmol/L indomethacin

               Figure 9. Effects of AM404 alone or in combination with the non-selective cyclooxygenase inhibitor indomethacin on lipopolysaccharide
               (LPS)-induced nitric oxide release. BV-2 cells were treated for 15 min with various concentrations of indomethacin (2, 20, 50 mmol/L), then
               incubated with different concentrations (2, 20, 50 mmol/L) of AM404 for a further 15 min period, before being stimulated with LPS.
               After 24 h, nitrite concentrations in the BV-2 cell-free supernatants were measured using the Griess assay. Data from four independent
               experiments are normalized against nitrite concentration in samples stimulated in the absence of inhibitors. Nitrite concentration in
               these samples was 26.6 ± 0.7 mmol/L. The effect of treatments was assessed by the two-way analyses of variance (ANOVA), followed by
               Tukey’s post hoc test. **P < 0.01, significantly different from stimulated cells incubated in the absence of indomethacin (ANOVA F = 102.3,
                                 ##
                        #
               P < 0.0001);  P < 0.05 and  P < 0.01, significantly different from stimulated cells incubated in the absence of AM404 (ANOVA F = 179,
               P < 0.0001). ANOVA interaction F = 1.79, P = 0.10
               (0.02, 0.5, 2 µmol/L) of the selective TRPV1 antagonist BCTC to block signaling through this receptor
               prior to the addition of p-aminophenol or AM404. If BCTC reduces the inhibitory activity of p-aminophenol
               or AM404 on NO secretion from stimulated microglia, it could be concluded that these metabolites
               of acetaminophen exert their effect through TRPV1 signaling. Figures 10 and 11 illustrate that both
   84   85   86   87   88   89   90   91   92   93   94